Review of the pharmacology, clinical efficacy, and safety of azelastine hydrochloride

References

• Dykewicz MS, Fineman S, Skoner DP et al. Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. 81, 478–518 (1998).
   PubMed Web of Science ®Google Scholar
• Settipane RA. Demographics and epidemiology of allergic and nonallergic rhinitis. Allergy Asthma Proc. 22, 185–189 (2001).
   PubMed Web of Science ®Google Scholar
• Ray NF, Baraniuk JN, Thamer M et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J. Allergy Clin. Immunol. 103, 401–407 (1999).
   PubMed Web of Science ®Google Scholar
• Bousquet J, van Cauwenberge PB, Khaltaev N et al. Allergic rhinitis and its impact on asthma: ARIA workshop report. J. Allergy Clin. Immunol. 108, S147–S334 (2001).
   PubMed Web of Science ®Google Scholar
• Bielory L, Ambrosio P. Conjunctivitis and allergic eye diseases. In: Current Reviews of Rhinitis. Kaliner MA (Ed.), Current Medicine, Inc., PA, USA 115–122 (2002).
   Google Scholar
• Lerrick AJ. A prospective, open-label evaluation of azelastine (Astelin®) nasal spray for the treatment of seasonal allergic rhinitis and perennial nonallergic (vasomotor) rhinitis. Today’s Therapeutic Trends 21, 215–226 (2003).
   Google Scholar
• White MV. Nasal cholinergic hyperresponsiveness in atopic subjects studied out of season. J. Allergy Clin. Immunol. 92, 278–287 (1993).
   Google Scholar
• Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J. Allergy Clin. Immunol. 108, S2–S8 (2001).
   PubMed Web of Science ®Google Scholar
• Economides A, Kaliner MA. Allergic rhinitis. In: Current Reviews of Rhinitis. Kaliner MA (Ed.), Current Medicine, Inc., PA, USA 35–51 (2002).
   Google Scholar
• Devyani L, Corey JP. Vasomotor rhinitis update. Curr. Opin. Otolaryngol. Head Neck Surg. 12(3), 243–247 (2004).
   PubMedGoogle Scholar
• Settipane RA, Settipane GA. Nonallergic rhinitis. In: Current Review of Rhinitis. Kaliner MA (Ed.), Current Medicine, Inc., PA, USA 53–65 (2002).
   Google Scholar
• LaForce C. Use of nasal steroids in managing allergic rhinitis. J. Allergy Clin. Immunol. 103, S388–S394 (1999).
   PubMed Web of Science ®Google Scholar
• Meltzer EO. Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study. Clin. Ther. 24, 942–952 (2002).
   PubMed Web of Science ®Google Scholar
• Graf P, Hallen H, Juto J. Four-week use of oxymetazoline nasal spray (Nezeril®) once daily at night induces rebound swelling and nasal hyperreactivity. Acta Otolarygol. 115, 71–75 (1995).
   PubMed Web of Science ®Google Scholar
• Pichler CE, Helbling A, Pichler WJ. Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy 56, 301–306 (2001).
   PubMed Web of Science ®Google Scholar
• Casale TB. The interaction of azelastine with human lung histamine H1, β, and muscarinic receptor-binding sites. J. Allergy Clin. Immunol. 83, 771–776 (1989).
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Pronzato C, Passalacqua G et al. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity. J. Allergy Clin. Immunol. 98, 1088–1096 (1996).
   PubMed Web of Science ®Google Scholar
• Shin MH, Baroody F, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. The effect of azelastine on the early allergic response. Clin. Exp. Allergy 22, 289–295 (1992).
   PubMed Web of Science ®Google Scholar
• Nieber K, Baumgarten C, Rathsack R et al. Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. Clin. Exp. Allergy 23, 69–71 (1993).
   PubMed Web of Science ®Google Scholar
• Ito H, Nakamura Y, Takagi S, Sakai K. Effects of azelastine on the level of serum interleukin-4 and soluble CD23 antigen in the treatment of nasal allergy. Arzneimittelforschung48, 1143–1147 (1998).
   PubMed Web of Science ®Google Scholar
• MedPointe Pharmaceuticals, data on file.
   Google Scholar
• Pearlman D, Grossman J, Meltzer E. Azelastine nasal spray and skin test reactivity to histamine in rhinitis patients. Ann. Allergy Asthma Immunol. 91, 258–262 (2003).
   Google Scholar
• Morganroth J, Perhach JL, Lyness W, Rosenberg A. Lack of effect of azelastine alone and coadministered with ketaconazole on electrocardiographic parameters. J. Allergy Clin. Immunol. 95, Abstract 282 (1995).
   Google Scholar
• Sale M, Lyness W, Perhach J, Woosley R, Rosenberg A. Lack of effect of coadministration of erythromycin with azelastine on pharmacokinetic or ECG parameters. Ann. Allergy Asthma Immunol. 76, Abstract 91 (1996).
   Google Scholar
• Zechel HJ, Brock N, Lenke D, Achterrath-Tuckermann U. Pharmacological and toxicological properties of azelastine, a novel anti-allergic agent. Arzneimittelforschung 31, 1184–1193 (1981).
   Google Scholar
• Inoue Y. Basic studies on antiallergy drug, 4-(p-chlorobenzyl)- 2[N-methyl- perhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride (azelastine). Nichi Idaishi. 50, 65–72 (1983).
   Google Scholar
• Katayama S, Akimoto N, Shionoya H, Morimoto T, Katoh Y. Anti-allergic effect of azelastine hydrochloride on immediate type hypersensitivity reaction in vivo and in vitro. Arzneimittelforschung 31, 1196–1203 (1981).
   PubMed Web of Science ®Google Scholar
• Takao A, Shimoda T, Matsuse H et al. Inhibitory effects of azelastine hydrochloride in alcohol-induced asthma. Ann. Allergy Asthma Immunol. 82, 390–394 (1999).
   PubMed Web of Science ®Google Scholar
• Howarth PH. Mediators of nasal blockage in allergic rhinitis. Allergy 52(Suppl 40), 12–18 (1997).
   PubMed Web of Science ®Google Scholar
• Katayama S, Tsunoda H, Sakuma Y et al. Effect of azelastine on the release and action of leukotriene C4 and D4. Int. Arch. Allergy Appl. Immunol. 83, 284–289 (1987).
   PubMedGoogle Scholar
• Matsumura M, Matsumoto Y, Takahashi H et al. Inhibitory effects of azelastine on leukotriene B4, C4, and D4 release and production from asthmatic eosinophils. Respir. Res. 9(2), 206–212 (1990).
   Google Scholar
• Hamasaki Y, Shafigeh M, Yamamoto S et al. Inhibition of leukotriene synthesis by azelastine. Ann. Allergy Asthma Immunol. 76, 469–475 (1996).
   PubMed Web of Science ®Google Scholar
• Hide I, Toriu N, Nuibe T et al. Suppression of TNF-α secretion by azelastine in a rat mast (RBL-2H3) cell line. J. Immunol. 159, 2932–2940 (1997).
   PubMed Web of Science ®Google Scholar
• Matsuo S, Takayama S. Influence of the anti-allergic agent, azelastine, on tumor necrosis factor-α (TNF-α) secretion from cultured mouse mast cells. In Vivo 12, 481–484 (1998).
   PubMed Web of Science ®Google Scholar
• Yoneda K, Yamamoto T, Ueta E, Osaki T. Suppression by azelastine hydrochloride of NF-κB activation involved in generation of cytokines and nitric oxide. Jpn. J. Pharmacol. 73, 145–153 (1997).
   PubMedGoogle Scholar
• Beck G, Mansur A, Afzal M et al. Effect of azelastine nasal spray on mediators of inflammation in patients with seasonal allergic rhinitis (SAR). Presented at American Academy of Allergy, Asthma, and Immunology 56th Annual Meeting, CA, USA, March 3–8, 2000.
   Google Scholar
• Ciprandi G, Cosentino C, Milanese M, Tosca MA. Rapid anti-inflammatory action of azelastine eye drops for ongoing allergic reactions. Ann. Allergy Asthma Immunol. 90, 434–438 (2003).
   PubMed Web of Science ®Google Scholar
• Busse W, Randley B, Sedgwick J, Sofia RD. The effect of azelastine on neutrophil and eosinophil generation of superoxide. J. Allergy Clin. Immunol. 83, 400–405 (1989).
   PubMed Web of Science ®Google Scholar
• Umeki S. Effects of antiallergic drugs on human neutrophil superoxide-generating NADPH oxidase. Biochem. Pharmacol. 43, 1109–1117 (1992).
   PubMed Web of Science ®Google Scholar
• Morita M, Ohshima Y, Akutagawa H et al. Inhibitory effects of azelastine hydrochloride on Ca2+ influx, actin polymerization and release of eosinophils cationic protein of an eosinophilic leukaemia cell line EoL-1. Curr. Med. Res. Opin. 13, 163–174 (1993).
   PubMed Web of Science ®Google Scholar
• Nakamura T, Nishizawa Y, Sato T, Yamato C. Effect of azelastine on the intracellular Ca2+ mobilization in guinea pig peritoneal macrophages. Eur. J. Pharmacol. 148, 35–41 (1988).
   PubMed Web of Science ®Google Scholar
• Weiler JM, Meltzer EO, Benson PM, Weiler K, Widlitz MD, Freitag J. A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model. J. Allergy Clin. Immunol. 94, 972–980 (1994).
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Weiler JM, Dockhorn RJ, Widlitz MD, Freitag JJ. Azelastine nasal spray in the management of seasonal allergic rhinitis. Ann. Allergy 72, 354–359 (1994).
   PubMedGoogle Scholar
• Ratner PH, Findlay SR, Hampel F, van Bavel J, Widlitz MD, Freitag JJ. A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis. J. Allergy Clin. Immunol. 94, 818–825 (1994).
   PubMed Web of Science ®Google Scholar
• Storms WW, Pearlman DS, Chervinsky P et al. Effectiveness of azelastine nasal solution in seasonal allergic rhinitis. Ear Nose Throat J. 73, 382–394 (1994).
   PubMedGoogle Scholar
• LaForce C, Dockhorn RJ, Prenner BM et al. Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 76, 181–188 (1996).
   PubMed Web of Science ®Google Scholar
• Berger WE, White MV, the Rhinitis Study Group. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Ann. Allergy Asthma Immunol. 91, 205–211 (2003).
   PubMed Web of Science ®Google Scholar
• LaForce CF, Corren J, Wheeler WJ et al. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. Ann. Allergy Asthma Immunol. 93, 154–159 (2004).
   PubMed Web of Science ®Google Scholar
• Corren J, Storms WW, Bernstein J et al. Effectiveness of azelastine nasal spray compared to oral cetirizine in patients with seasonal allergic rhinitis. Clin. Ther. 27, 543–553 (2005).
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Andersson B, Ferrie PJ. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann. Allergy 70, 225–230 (1993).
   Google Scholar
• Lieberman P, Kaliner MA, Wheeler WJ. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis. Curr. Med. Res. Opin. 21, 611–618 (2005).
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Ricca V, Passalacqua G et al. Seasonal rhinitis and azelastine: long- or short-term treatment? J. Allergy Clin. Immunol. 99, 301–307 (1997).
   PubMed Web of Science ®Google Scholar
• Banov C, Lieberman P. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann. Allergy Asthma Immunol. 86, 28–35 (2001).
   PubMed Web of Science ®Google Scholar
• Berlin JM, Golden SJ, Teets S, Lehman EB, Lucas T, Craig TJ. Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J. Am. Osteopath. Assoc. 100, S8–S13 (2000).
   PubMedGoogle Scholar
• Physician Survey Sponsored by the American College of Allergy, Asthma and Immunology. Rochester, NY, USA: Harris Interactive Inc; October 19–29, 2001 (2000).
   Google Scholar